跳至主要内容
临床试验/NCT04976920
NCT04976920招募中不适用

Non-selection Trial Comparing Metabolomics to PGT-A Embryo Selection Using Vitrolife G-TL Media

Overture Life2 个研究点 分布在 2 个国家目标入组 205 人开始时间: 2021年7月12日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
205
试验地点
2
主要终点
Negative predictive value (NPV) and positive predictive value (PPV) for MEI vs. expected implantation based solely on morphology.

研究概览

简要总结

In this study, study investigators will collect embryo culture media on day 5 of vitro fertilization (IVF) culture, prior to vitrification and embryo transfer for testing via Metabolomic screening. Metabolomics is a new, non-invasive method of embryo selection which involves testing discarded embryo culture media for analytes secreted by the developing embryo. These analytes can be used to determine the implantation potential, and ploidy, of the embryo.

详细描述

Patients will undergo a routine IVF cycle. This will include ovarian stimulation, egg retrieval and fertilization of oocytes through intracytoplasmic sperm injection (ICSI). All fertilized oocytes will be cultured up to blastocyst for five to six days.

Spent media will be collected on day 5-6 for all embryos reaching blastocyst on day 5, and on day 6 for those reaching blastocyst on day 6. The spent culture media will be sent to a lab for metabolomic analysis.

For the embryo transfer, the best morphology blastocyst will be selected for transfer by the New Hope embryologist.

Approximately 8-11 days after the embryo transfer, the patient will return to the clinic for a serum pregnancy test. Should the test be negative, they will be closed out of the study. Should the test be positive, they will continue to be monitored.

The patient will return to the clinic at approximately 8 weeks after embryo transfer for a serum pregnancy test, and an ultrasound to detect fetal heartbeat. The outcome will be documented and the patient closed out of the study at this time.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 38 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women of any age, 25% of patients <35 years, 25% of patients 35-37, 25% of patients 38-40, and 25% of patients >40 years.
  • Signed Subject Consent Form. No inferior limit on number of eggs

排除标准

  • At the time of initial visit:
  • Require or request PGT of any kind
  • Low ovarian reserve defined as follicle stimulating hormone (FSH) >10 IU/L on day 2-4 of a prior menstrual cycle and anti-mullerian hormone (AMH) <15 pmol/L (or <2 ng/ml) within prior 12 months of cycle start
  • At the time of embryo selection:
  • Patients without at least one embryo to transfer.

结局指标

主要结局

Negative predictive value (NPV) and positive predictive value (PPV) for MEI vs. expected implantation based solely on morphology.

时间窗: Approximately 4-5 months, inclusive of IVF cycle, embryo transfer and monitoring up to eight weeks

PPV (MEI high potential implanting / Total implanting), NPV (MEI low potential implanting / Total not implanting)

次要结局

未报告次要终点

研究者

发起方
Overture Life
申办方类型
Industry
责任方
Principal Investigator
主要研究者

Dr. Jose Horcajadas

Principal Investigator

Overture Life

研究点 (2)

Loading locations...

相似试验

Metabolomics Non Selection Study - Vitrolife Media | 临床试验